Precision medicine is a method of improving patient outcomes by combining clinical and molecular patient data to better understand the disease's biological foundation. Precision medicine tailors treatment to a patient's unique traits, making it more exact in terms of how treatment affects specific individuals. Clinical trials are studies in which investigational drugs, technologies, or biologics, such as chemotherapy, blood products, or gene treatments, are tested for safety and efficacy in human volunteers. Building a therapy hypothesis, determining which patients react and why, and developing effective procedures for identifying those patients are all steps in precision medicine. The method entails considering drug delivery, biomarker response, and the diagnostic tool for locating the appropriate individuals. Clinical trials and medical therapy can become more successful, efficacious, and efficient as medicines are identified based on analytics. Clinical trials for precision medicine have several ethical and regulatory difficulties in common with clinical trials in general.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States